MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ofid/ofag426

Медицинская библиотека · Open forum infectious diseases · 2026

Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

Rial-Crestelo David, Llenas-García Jara, Hidalgo-Tenorio Carmen, Troya García Jesús, Galindo Puerto María José, Alemán Valls María Remedios, Torralba González de Suso Miguel, Buzón Luis, Díaz de Santiago Alberto, Rodríguez Adrián, Calzado Isbert Sonia, Aguilera García María, Morano Amado Luis Enrique, Vinuesa García David, Bernal Morell Enrique, Martínez Álvarez Rosa María, Cabello-Clotet Noemí, Fernández Analuz, Montero Hernández María Del Carmen, Díez Romero Cristina, Calderón Hernaiz Ruth, Pérez Martínez Desiree, Gisbert Pérez Laura, Arenas García Víctor, Escrich Cristina, Fariñas Álvarez María Carmen, Lucas Dato Ana, Losa García Juan Emilio, Pernas Pardavila Hadrián, Gainzarain Juan Carlos, Estébanez Miriam, Barragán Gallo Patricia, Clavero Olmos Marta, Egido Murciano Miguel Vicente, Benéitez Oscar Luis Ferrero, Pedrero-Tomé Roberto, Cabello-Úbeda Alfonso, Martín-Carbonero Luz, RELATIVITY studygroup

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The impact of pre-existing non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations (RAMs) on the effectiveness of long-acting (LA) cabotegravir (CAB) and rilpivirine (RPV) remains poorly defined, particularly for mutations like K103N that do not directly compromise RPV susceptibility (non-RPV NNRTI RAMs).

METHODS

This observational substudy within the Spanish RELATIVITY cohort included people with HIV (PWH) who switched to CAB + RPV LA before 2025. We compared virologic outcomes between those with non-RPV NNRTI RAMs and a reference group without NNRTI/INSTI-RAMs or prior NNRTI-based virologic failure (VF). An additional subgroup with RPV-associated RAMs was also analyzed. Confirmed virologic failure (CVF) was defined as 2 consecutive viral loads ≥ 200 copies/mL or 1 ≥500 copies/mL.

RESULTS

Among 1358 participants, 83 (6.1%) harbored non-RPV NNRTI RAMs (47 with K103N) and 1247 served as the reference group. After a median follow-up of 16.7 months, CVF rates were similar between the non-RPV NNRTI RAMs group and the reference group (1.2% vs 0.8%; HR: 1.39; 95% CI: 0.18-10.84; P = .755). No significant differences were observed in viral blips (6% vs 8.2%; P = .481). Notably, in the subgroup of 28 participants with RPV-associated RAMs (including 5 with high-level resistance), no CVFs occurred over a median of 13.5 months.

CONCLUSIONS

In a real-world setting, CAB + RPV LA demonstrated high effectiveness in PWH with pre-existing NNRTI RAMs that do not compromise RPV susceptibility, including K103N. While no failures were seen in those with RPV-associated RAMs, these results should be interpreted with caution due to the small sample size.

Для цитирования: Rial-Crestelo David, Llenas-García Jara, Hidalgo-Tenorio Carmen, Troya García Jesús, Galindo Puerto María José, Alemán Valls María Remedios, Torralba González de Suso Miguel, Buzón Luis, Díaz de Santiago Alberto, Rodríguez Adrián, Calzado Isbert Sonia, Aguilera García María, Morano Amado Luis Enrique, Vinuesa García David, Bernal Morell Enrique, Martínez Álvarez Rosa María, Cabello-Clotet Noemí, Fernández Analuz, Montero Hernández María Del Carmen, Díez Romero Cristina, Calderón Hernaiz Ruth, Pérez Martínez Desiree, Gisbert Pérez Laura, Arenas García Víctor, Escrich Cristina, Fariñas Álvarez María Carmen, Lucas Dato Ana, Losa García Juan Emilio, Pernas Pardavila Hadrián, Gainzarain Juan Carlos, Estébanez Miriam, Barragán Gallo Patricia, Clavero Olmos Marta, Egido Murciano Miguel Vicente, Benéitez Oscar Luis Ferrero, Pedrero-Tomé Roberto, Cabello-Úbeda Alfonso, Martín-Carbonero Luz, RELATIVITY studygroup. Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.. Open forum infectious diseases. 2026. DOI: 10.1093/ofid/ofag426.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.